CN1136436A - Tablet for clearing head for cerebrorascular disease - Google Patents
Tablet for clearing head for cerebrorascular disease Download PDFInfo
- Publication number
- CN1136436A CN1136436A CN96116211A CN96116211A CN1136436A CN 1136436 A CN1136436 A CN 1136436A CN 96116211 A CN96116211 A CN 96116211A CN 96116211 A CN96116211 A CN 96116211A CN 1136436 A CN1136436 A CN 1136436A
- Authority
- CN
- China
- Prior art keywords
- tablet
- vitamin
- cerebrorascular
- disease
- clearing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
The present invention discloses a kind of medicine for anticerebrovascular diseases. It is mainly composed of pyra-thio-alcohol, valium, VB1, VB6, chondroitin sulfate, sodium glycerophosphate, and lysine for curing senile dementia, sequel of cerebro trauma, dizzy headache after encephalitis and meningitis, vertigo, insomnia, amnesia, diverting attention and morale variation etc..
Description
The present invention relates to the sick new drug of a kind of resisting cerebrovascular.
The various mental disorders that dementia that cerebral hypoplasia, brain atrophy cause and cerebrovascular ischemia cause, it is one of common encephalopathy of old people and child, the lighter can cause symptoms such as neurasthenia, hypomnesis, insomnia, lassitude, weight person can make patient's loss of consciousness, can't take care of oneself, make patient and family members all very painful.
The objective of the invention is: provide a kind of resisting cerebrovascular sick new drug--clearing brain tablet, it is for the alzheimer disease psychosis, cerebral trauma sequela, distending pain in the head behind encephalitis and the meningitis, dizzy insomnia, hypomnesis, absent minded, the improvement of emotion changes symptom and climacteric syndrome etc. all have special effect.
Technical scheme of the present invention is:
A kind of clearing brain tablet, its prescription comprises following component:
A. pyritinol 18--22;
B. stable 1.2--1.3;
C. vitamin B1 4.5--5.5;
D. vitamin B6 4.5--5.5;
E. Margarita powder 45--55;
F. chondroitin sulfate 27--33;
G. sodium glycerophosphate 27--33;
H. lysine 90--110.
Also contain proper quantity of medicinal auxiliary material in the described prescription, be beneficial to make tablet; Described pharmaceutic adjuvant is starch and dolomol.
Advantage of the present invention is:
1. can promote glucose and amino acid metabolism in the brain, improve the whole body assimilation, increase the carotid artery flow amount, improve cerebral blood flow, improve the cerebral biological electricity activity, finally make brain function obtain taking a turn for the better.
2. the aminoacid that has human body necessity--lysine, it can see through blood brain barrier and enter cerebral tissue, helps the neurocyte reparation, promotes the physiological function of nervous cell regenerating and anti-cerebral hypoxia, memory reinforcing.
3. have calmness, spasmolytic, analgesic activity, can be used for nervous migraine.
4. can obviously improve ischemia and give birth to tissue blood flow, improve cerebral infarction patient motion function and recover.
The invention will be further described below in conjunction with embodiment:
Embodiment: a kind of clearing brain tablet, adopt following prescription:
A. pyritinol 20;
B. stabilize 1.25;
C. vitamin B1 5;
D. vitamin B6 5;
E. Margarita powder 50;
F. chondroitin sulfate 30;
G. sodium glycerophosphate 30;
H. lysine 100.
Adopt following technology: powder such as pyritinol, stable, vitamin B1, vitamin B6, chondroitin sulfate, sodium glycerophosphate lysine are crossed 100 mesh sieves, add starch slurry 10%, mixed and stirred the back and cross 60 mesh sieves, 60 ℃ of oven dry, add an amount of hard acid magnesium powder, tabletting, sugar coating.
The present invention is for the alzheimer disease psychosis, cerebral trauma sequela, and the distending pain in the head behind encephalitis and the meningitis, dizzy insomnia, hypomnesis, absent minded, the improvement of emotion changes symptom and climacteric syndrome etc. all have special effect.
Claims (3)
1. clearing brain tablet, its prescription comprises following component:
A. pyritinol 18--22;
B. stable 1.2--1.3;
C. vitamin B1 4.5--5.5;
D. vitamin B6 4.5--5.5;
E. Margarita powder 45--55;
F. chondroitin sulfate 27--33;
G. sodium glycerophosphate 27--33;
H. lysine 90--110.
2. clearing brain tablet according to claim 1 is characterized in that: also contain proper quantity of medicinal auxiliary material in the described prescription, be beneficial to make tablet.
3. clearing brain tablet according to claim 2 is characterized in that: described pharmaceutic adjuvant is starch and dolomol.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN96116211A CN1061536C (en) | 1996-01-09 | 1996-01-09 | Tablet for clearing head for cerebrorascular disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN96116211A CN1061536C (en) | 1996-01-09 | 1996-01-09 | Tablet for clearing head for cerebrorascular disease |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1136436A true CN1136436A (en) | 1996-11-27 |
CN1061536C CN1061536C (en) | 2001-02-07 |
Family
ID=5123333
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN96116211A Expired - Fee Related CN1061536C (en) | 1996-01-09 | 1996-01-09 | Tablet for clearing head for cerebrorascular disease |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1061536C (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105520991A (en) * | 2015-12-09 | 2016-04-27 | 贵州神奇药物研究院 | Health product capable of preventing senile dementia and preparation method for health product |
CN108936669A (en) * | 2018-09-25 | 2018-12-07 | 泓博元生命科技(深圳)有限公司 | Improve the composition and the preparation method and application thereof of memory |
CN109170891A (en) * | 2018-09-25 | 2019-01-11 | 泓博元生命科技(深圳)有限公司 | A kind of composition and the preparation method and application thereof improving memory |
-
1996
- 1996-01-09 CN CN96116211A patent/CN1061536C/en not_active Expired - Fee Related
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105520991A (en) * | 2015-12-09 | 2016-04-27 | 贵州神奇药物研究院 | Health product capable of preventing senile dementia and preparation method for health product |
CN108936669A (en) * | 2018-09-25 | 2018-12-07 | 泓博元生命科技(深圳)有限公司 | Improve the composition and the preparation method and application thereof of memory |
CN109170891A (en) * | 2018-09-25 | 2019-01-11 | 泓博元生命科技(深圳)有限公司 | A kind of composition and the preparation method and application thereof improving memory |
Also Published As
Publication number | Publication date |
---|---|
CN1061536C (en) | 2001-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2000514437A (en) | Use of L-acetylcarnitine, L-isovalerylcarnitine, L-propionylcarnitine to increase IGF-1 levels | |
CN1061536C (en) | Tablet for clearing head for cerebrorascular disease | |
CN103649106B (en) | Be used for the treatment of compound and the pharmaceutical composition of nervus retrogression and ischemic cerebral disease | |
CN103372135A (en) | Chinese medicinal composition treating cardiovascular and cerebrovascular diseases caused by heart-kidney imbalance | |
CN101455359A (en) | Oral preparation capable of promoting blood, reducing fat and protecting and strengthening health and preparation method thereof | |
CN101032599B (en) | Healthy solution for conditioning skin and losing weight | |
CN112957413A (en) | Traditional Chinese medicine composition for regulating and treating insomnia and preparation method | |
CN102283940B (en) | Chinese medicinal preparation for treating palpitation | |
CN1048408C (en) | Medicine for curing nervous system injury and angionosis | |
CN102228618B (en) | Chinese medicinal powder for treating ischemic heart disease | |
CN1234393C (en) | Chinese patent drug for treating primary hypopiesi | |
CN111658917A (en) | Health care device for heart and brain health, reducing blood pressure and tonifying primordial qi of human body | |
CN1240654A (en) | Compound gingko-red sage tablet and its preparing process | |
CN1057672C (en) | Styracol tablet | |
CN1326549C (en) | Chinese medicine for treating blood vessel nature feeble-mindedness | |
CN1114425C (en) | Chinese patent medicine for treating coronary heart disease and hypertension | |
CN101559139A (en) | Prescription of pure traditional Chinese medicine preparation for preventing and curing neurasthenia insomnia and preparation method thereof | |
CN1320905C (en) | Inflammation-resisting pain-stopping preparation | |
CN114306548B (en) | Traditional Chinese medicine composition for treating insomnia and application thereof | |
CN2595397Y (en) | Pressure reducing cup | |
EP3622964B1 (en) | Agent for the treatment of skin wounds or burns | |
CN1256142C (en) | Chinese medicine for treating side reaction caused by insanity resisting medicine and its preparation method | |
CN1062461C (en) | Senility-proof health medicine | |
CN1879760A (en) | Compound medicine for treating high paralysis, fracture sequelae, cardiac infarction and splenomegaly | |
CN1231230C (en) | Apoplexy treating capsule and its preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |